BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17848951)

  • 41. Array-based DNA methylation profiling for breast cancer subtype discrimination.
    Van der Auwera I; Yu W; Suo L; Van Neste L; van Dam P; Van Marck EA; Pauwels P; Vermeulen PB; Dirix LY; Van Laere SJ
    PLoS One; 2010 Sep; 5(9):e12616. PubMed ID: 20830311
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer.
    Iwamoto T; Bianchini G; Qi Y; Cristofanilli M; Lucci A; Woodward WA; Reuben JM; Matsuoka J; Gong Y; Krishnamurthy S; Valero V; Hortobagyi GN; Robertson F; Symmans WF; Pusztai L; Ueno NT
    Breast Cancer Res Treat; 2011 Feb; 125(3):785-95. PubMed ID: 21153052
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene expression profiling of breast tumours from New Zealand patients.
    Muthukaruppan A; Lasham A; Blenkiron C; Woad KJ; Black MA; Knowlton N; McCarthy N; Findlay MP; Print CG; Shelling AN
    N Z Med J; 2017 Oct; 130(1464):40-56. PubMed ID: 29073656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Update on inflammatory breast cancer.
    Lerebours F; Bieche I; Lidereau R
    Breast Cancer Res; 2005; 7(2):52-8. PubMed ID: 15743511
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gene-expression signature functional annotation of breast cancer tumours in function of age.
    Jézéquel P; Sharif Z; Lasla H; Gouraud W; Guérin-Charbonnel C; Campion L; Chrétien S; Campone M
    BMC Med Genomics; 2015 Nov; 8():80. PubMed ID: 26597277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mammary stem cell and macrophage markers are enriched in normal tissue adjacent to inflammatory breast cancer.
    Reddy JP; Atkinson RL; Larson R; Burks JK; Smith D; Debeb BG; Ruffell B; Creighton CJ; Bambhroliya A; Reuben JM; Van Laere SJ; Krishnamurthy S; Symmans WF; Brewster AM; Woodward WA
    Breast Cancer Res Treat; 2018 Sep; 171(2):283-293. PubMed ID: 29858753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemoglobin overexpression and splice signature as new features of inflammatory breast cancer?
    Lerebours F; Vacher S; Guinebretiere JM; Rondeau S; Caly M; Gentien D; Van Laere S; Bertucci F; de la Grange P; Bièche L; Liang X; Callens C
    J Adv Res; 2021 Feb; 28():77-85. PubMed ID: 33364047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular determinants of the inflammatory breast cancer phenotype.
    Houchens NW; Merajver SD
    Oncology (Williston Park); 2008 Dec; 22(14):1556-61; discussion 1561, 1565-8, 1576. PubMed ID: 19198217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genomic and expression analysis of microdissected inflammatory breast cancer.
    Woodward WA; Krishnamurthy S; Yamauchi H; El-Zein R; Ogura D; Kitadai E; Niwa S; Cristofanilli M; Vermeulen P; Dirix L; Viens P; van Laere S; Bertucci F; Reuben JM; Ueno NT
    Breast Cancer Res Treat; 2013 Apr; 138(3):761-72. PubMed ID: 23568481
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature.
    Bièche I; Lerebours F; Tozlu S; Espie M; Marty M; Lidereau R
    Clin Cancer Res; 2004 Oct; 10(20):6789-95. PubMed ID: 15501955
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential Gene Expression of fresh tissue and patient-derived explants' matricellular proteins augment inflammatory breast cancer metastasis: the possible role of IL-6 and MCP-1.
    Tarek A; Mohamed HT; El-Sharkawy AA; El-Sayed SK; Hirshon JM; Woodward WA; El-Shinawi M; Mohamed MM
    QJM; 2023 May; 116(5):345-354. PubMed ID: 36592055
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Infrared Microspectroscopy and Imaging Analysis of Inflammatory and Non-Inflammatory Breast Cancer Cells and Their GAG Secretome.
    Mohamed HT; Untereiner V; Cinque G; Ibrahim SA; Götte M; Nguyen NQ; Rivet R; Sockalingum GD; Brézillon S
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32961706
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Robust inflammatory breast cancer gene signature using nonparametric random forest analysis.
    Zare A; Postovit LM; Githaka JM
    Breast Cancer Res; 2021 Sep; 23(1):92. PubMed ID: 34579745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of genes and critical control proteins associated with inflammatory breast cancer using network controllability.
    Wakai R; Ishitsuka M; Kishimoto T; Ochiai T; Nacher JC
    PLoS One; 2017; 12(11):e0186353. PubMed ID: 29108005
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features.
    Haakensen VD; Lingjaerde OC; Lüders T; Riis M; Prat A; Troester MA; Holmen MM; Frantzen JO; Romundstad L; Navjord D; Bukholm IK; Johannesen TB; Perou CM; Ursin G; Kristensen VN; Børresen-Dale AL; Helland A
    BMC Med Genomics; 2011 Nov; 4():77. PubMed ID: 22044755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene expression profiles of inflammatory breast cancer reveal high heterogeneity across the epithelial-hybrid-mesenchymal spectrum.
    Chakraborty P; George JT; Woodward WA; Levine H; Jolly MK
    Transl Oncol; 2021 Apr; 14(4):101026. PubMed ID: 33535154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deciphering the molecular biology of inflammatory breast cancer through molecular characterization of patient samples and preclinical models.
    Rypens C; Van Berckelaer C; Berditchevski F; van Dam P; Van Laere S
    Int Rev Cell Mol Biol; 2024; 384():77-112. PubMed ID: 38637101
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammatory Breast Cancer: Clinical Implications of Genomic Alterations and Mutational Profiling.
    Faldoni FLC; Villacis RAR; Canto LM; Fonseca-Alves CE; Cury SS; Larsen SJ; Aagaard MM; Souza CP; Scapulatempo-Neto C; Osório CABT; Baumbach J; Marchi FA; Rogatto SR
    Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 33007869
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular portraits of human breast tumours.
    Perou CM; Sørlie T; Eisen MB; van de Rijn M; Jeffrey SS; Rees CA; Pollack JR; Ross DT; Johnsen H; Akslen LA; Fluge O; Pergamenschikov A; Williams C; Zhu SX; Lønning PE; Børresen-Dale AL; Brown PO; Botstein D
    Nature; 2000 Aug; 406(6797):747-52. PubMed ID: 10963602
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inflammatory breast cancer: New factors contribute to disease etiology: A review.
    Mohamed MM; Al-Raawi D; Sabet SF; El-Shinawi M
    J Adv Res; 2014 Sep; 5(5):525-36. PubMed ID: 25685520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.